UVADEX is a Extracorporeal Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Therakos, Inc.. The primary component is Methoxsalen.
| Product ID | 64067-216_6c5b68f2-b4b9-434b-9036-22d1b37bf68b |
| NDC | 64067-216 |
| Product Type | Human Prescription Drug |
| Proprietary Name | UVADEX |
| Generic Name | Methoxsalen |
| Dosage Form | Injection, Solution |
| Route of Administration | EXTRACORPOREAL |
| Marketing Start Date | 1999-02-25 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020969 |
| Labeler Name | Therakos, Inc. |
| Substance Name | METHOXSALEN |
| Active Ingredient Strength | 20 ug/mL |
| Pharm Classes | Psoralen [EPC],Psoralens [CS],Photoabsorption [MoA],Photoactivated Radical Generator [EPC],Photosensitizing Activity [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 1999-02-25 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020969 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1999-02-25 |
| Ingredient | Strength |
|---|---|
| METHOXSALEN | 20 ug/mL |
| SPL SET ID: | 5ad333bd-845f-43f8-9ecf-43491f26c7c7 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 64067-216 | UVADEX | Methoxsalen |
| 45963-325 | Methoxsalen | Methoxsalen |
| 64380-752 | Methoxsalen | Methoxsalen |
| 68682-065 | Methoxsalen | Methoxsalen |
| 0187-0650 | Oxsoralen-Ultra | Methoxsalen |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() UVADEX 85319332 4074104 Live/Registered |
MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED 2011-05-12 |
![]() UVADEX 77489275 4006506 Live/Registered |
MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED 2008-06-03 |
![]() UVADEX 76549044 2891030 Dead/Cancelled |
JOHNSON & JOHNSON 2003-10-06 |
![]() UVADEX 73169280 1119084 Dead/Expired |
HOFFMANN-LA ROCHE INC. 1978-05-05 |